Bacteroides

Bacteroides is a genus of Gram-negative, rod-shaped bacteria. Bacteroides species are non-endospore-forming, anaerobes, and may either be motile or non-motile, depending on the species.^[1] The DNA base composition is 40-48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

Bacteroides are normally commensal, making up the most substantial portion of the mammalian gastrointestinal flora,^[2] where they play a fundamental role in processing of complex molecules to simpler ones in the host intestine. As many as 10¹⁰-10¹¹ cells per gram of human feces have been reported.^[3] They can use simple sugars when available, but the main source of energy is polysaccharides from plant sources.

Additional recommended knowledge

Daily Sensitivity Test

Daily Visual Balance Check

Don't let static charges disrupt your weighing accuracy

Pathogenesis

Bacteroides species also benefit their host by excluding potential pathogens from colonizing the gut. Some species (B. fragilis, for example) are opportunistic human pathogens, causing infections of the peritoneal cavity, gastrointestinal surgery, and appendicitis via abscess formation, inhibiting phagocytosis, and inactivating beta-lactam antibiotics.^[4] Although Bacteroides species are anaerobic, they are aerotolerant and thus can survive in the abdominal cavity.

Bacteroides are generally resistant to a wide variety of antibiotics — β-lactams, aminoglycosides, and recently many species have acquired resistance to erythromycin and tetracycline. This high level of antibiotic resistance has prompted concerns that Bacteroides species may become a reservoir for resistance in other, more highly pathogenic bacterial strains.^[5]

B. fragilis

Bacteroides fragilis is an obligate anaerobe of the gut. It is involved in 90% of anaerobic peritoneal infections.^{[citation needed]} B. fragilis is generally susceptible to metronidazole, carbapenems, and beta-lactam/beta-lactamase inhibitor combinations (e.g., Unasyn, Zosyn). The bacteria has inherent high-level resistance to penicillin. Clindamycin is no longer recommended as the first-line agent for B. fragilis due to emerging high-level resistance (>30% in some reports).^[6]

References

See also

• Flavobacterium
• Cytophaga